Pfizer, Inc. vs Thermo Fisher Scientific Inc — Stock Comparison
Pfizer, Inc. (PFE) and Thermo Fisher Scientific Inc (TMO) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
Thermo Fisher Scientific Inc scores ahead of Pfizer, Inc. on Q·Score (7.5 vs 6.2 out of 10), led by Sentiment (8.1 vs 5.3) and Quality (7.7 vs 6.4). Analyst consensus targets imply greater upside for TMO (+29.8%) than for PFE (+12.6%).
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
Consistently beats earnings estimates (4/4 quarters).
⚠ earnings contracting 10% year-over-year.
Consensus analyst target of $599.19 is 30% above current price.
Analyst Consensus
Fundamentals
Frequently Asked Questions
PFE vs TMO: which stock scores better overall?
Based on Q·Score, Thermo Fisher Scientific Inc (TMO) scores 7.5/10 versus Pfizer, Inc. (PFE) at 6.2/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: PFE or TMO?
Thermo Fisher Scientific Inc (TMO) scores higher on Growth (6.1/10 vs 5.1/10). Pfizer, Inc. reports revenue growth (5.4% YoY) while Thermo Fisher Scientific Inc reports (6.2% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.
Is PFE or TMO more attractively valued?
Thermo Fisher Scientific Inc (TMO) scores higher on Valuation (8.2/10 vs 7/10). PFE trades at 9.2× P/E versus TMO at 16.9×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about PFE vs TMO?
There are 27 analysts covering PFE with a consensus price target of $29.19, and 26 analysts covering TMO with a consensus target of $599.19. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: PFE or TMO?
Thermo Fisher Scientific Inc (TMO) scores higher on Quality (7.7/10 vs 6.4/10). Net profit margin: PFE at 11.8%, TMO at 15.2%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: PFE or TMO?
Thermo Fisher Scientific Inc (TMO) scores higher on Financial Health (7.6/10 vs 7/10). Market beta: PFE at 0.29, TMO at 0.87. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of PFE and TMO?
Pfizer, Inc. (PFE) has a market capitalisation of $147.7B, while Thermo Fisher Scientific Inc (TMO) has a market cap of $171.6B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Do PFE or TMO pay dividends?
PFE pays a dividend yield of 6.61%, while TMO pays a dividend yield of 0.40%. Dividend yields fluctuate with share price and company payout decisions.
Related Comparisons
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →